SBIR/STTR Research Award

Dual-view endoscopic probe

Award identifier a9d71eeda8342eb733a5fc745b406b2853941f55faf30d159698d21186ab3429Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$223,761

Program and phase

STTR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
OMNISCIENT IMAGING INC
Proposal award date
2016-05-01
Contract end date
2018-01-31
UEI
LLN8BBEKWBN5
Solicitation number
PA14-072
Topic code
102

Research abstract

DESCRIPTION provided by applicant Colon cancer is a leading cause of cancer death in the United States and overseas Colonoscopy is the preferred screening method at an estimated annual cost of over $ billion in the US Unfortunately many lesions are missed because pre cancerous growths remain hidden from view behind folds and flexures of the colon Current methods of increasing the field of view are ineffective and some are very expensive which hampers adoption of these methods into clinical practice A proprietary dual view imaging method has been developed that illuminates and images forward as well as backwards in degrees and produces a single image A proof of concept prototype has been successfully developed but is too large to be used with a colonoscopy Omniscient LLC will license the method from the University of Arizona and construct a dual view optical probe that is small enough to be passed through the biopsy channel of a standard colonoscopy Omniscient LLC will develop software which combines both views in a single video display and optimize image quality The probe will be tested in standard colonoscopy models with simulated polyps in areas that are easy to see as well as those hidden from forward view The probe will be passed through the biopsy channel of the standard colonoscopy and its performance will be compared to that of the standard colonoscopy alone Successful completion of this Phase I STTR project will lead to a dual view probe which can be used with standard colonoscopy and is suitable for clinical testing PUBLIC HEALTH RELEVANCE Colonoscopy is a common cancer screening procedure that is far from perfect and one of its major flaws is that the physician is unable to view large areas of the colon hidden behind folds which leads to missed pre cancerous growths and the unexpected early development of cancer Omniscient LLC will license a proprietary method of seeing forwards and backwards in a single image construct and test a probe that is small enough to be passed through the instrument channel in endoscopes When used in patients this will allow the entire colon to be seen prevent cancer and reduce the number of procedures a person needs

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2016–2022). Reported award amounts total $4,559,221. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.